Skip to main content

High number of tumour-infiltrating lymphocytes is associated with apoptosis in non-small cell lung carcinoma

Buy Article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Aim: To test whether the number of tumour-infiltrating mononuclear cells (MNC), namely T-lymphocytes (TIL) and, to a lesser degree, B-lymphocytes and macrophages, is associated with tumour cell apoptosis in non-small cell lung carcinoma (NSCLC). Methods and results: Eighty-four non-small cell lung tumours were analysed with specific antibodies and the extent of apoptosis was determined using 3′-end labelling of fragmented DNA (TUNEL). All parameters were determined from the same tumour areas. In general, adenocarcinomas showed a higher number of MNC than squamous cell carcinomas (p=0.04). The number of MNC increased concurrently with the grade of tumour, occurrence being highest in high grade (III) tumours (p=0.05). The number of apoptotic cells was significantly higher in tumours with a high number of CD3+ and CD8+ lymphocytes (p=0.01) and B-cells (p=0.05). Tumours showing abnormal p53 protein expression had a significantly lower count of CD8+ T-cells compared to p53-negative tumours (p=0.03). Conclusions: Our results showed an association between lymphocytic infiltration and extent of apoptosis in NSCLC, suggesting that an attempt to suppress the growth of transformed tumour cells exists even when the tumour has reached an advanced stage.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: Apoptosis; TIL; non-small cell lung carcinoma

Document Type: Original Article

Affiliations: Department of Pathology, University of Oulu, and Oulu University Hospital, Oulu, Finland

Publication date: 2001-08-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more